NFA
FLGT icon

Nationwide Fund Advisors’s Fulgent Genetics FLGT Stock Holding History

Nationwide Fund Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-55,295
Closed -$604K – 3216
2017
Q1 		$604K Sell
55,295
-17,560
-24% -$208K ﹤0.01% 2049
2016
Q4 		$843K Hold
72,855
– – ﹤0.01% 1875
2016
Q3 		$672K Buy
+72,855
New +$670K ﹤0.01% 2014

Other funds holding FLGT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
SC
Scholtz & Company Stamford, Connecticut $200M AUM 12.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
ECM
Element Capital Management New York $3.2B AUM 29.54% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Nationwide Fund Advisors's FLGT Position: Q2 2017 in Review

Nationwide Fund Advisors sold out of Fulgent Genetics (FLGT) in Q2 2017, closing a stake of 55,295 shares — an estimated $604K sold.

Nationwide Fund Advisors first reported a position in FLGT in Q3 2016 and held it in 3 quarters. The position peaked at $843K in Q4 2016. 22 funds tracked by Wall St. Rank hold FLGT as of Q2 2017.

  • Nationwide Fund Advisors reported no remaining Fulgent Genetics position as of Q2 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 55,295 Fulgent Genetics shares in Q2 2017, an estimated $604K.
  • Nationwide Fund Advisors first reported a position in Fulgent Genetics in Q3 2016 and held it in 3 quarters.
  • Nationwide Fund Advisors's Fulgent Genetics position peaked at $843K in Q4 2016.
  • 22 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2017.

Based on Nationwide Fund Advisors's 13F filing for Q2 2017, filed 10 Aug 2017.